Blood Pressure Guidelines for a 67-Year-Old with CKD
Target a systolic blood pressure <120 mmHg using standardized office measurement techniques for this 67-year-old patient with CKD. 1, 2
BP Target Recommendation
The KDIGO 2021 guideline establishes SBP <120 mmHg as the default target for adults with CKD not on dialysis, based primarily on the SPRINT trial evidence showing cardiovascular and mortality benefits 1, 2. At age 67, this patient falls within the age range where evidence is strongest—the guideline specifically notes that older adults comprised a substantial proportion of SPRINT participants, making this target well-supported for this age group 1.
Critical Measurement Requirement
This <120 mmHg target applies ONLY to standardized office BP measurement, not routine office BP. This distinction is non-negotiable 1, 2. Standardized measurement requires:
- 5-minute quiet rest period before measurement
- Patient seated alone or with minimal observer presence
- Automated device taking average of 3 readings
- Proper patient positioning and cuff placement 2, 3
Using routine office BP with this target risks overtreatment and adverse events 2. The Work Group made this a strong recommendation because routine office BP is unreliable and would not be acceptable for other physiologic measurements 2.
Pharmacologic Approach
Start with combination therapy using a renin-angiotensin system (RAS) inhibitor plus either a calcium channel blocker or diuretic 1, 4. RAS inhibitors are particularly important if the patient has:
Consider adding SGLT2 inhibitors for nephroprotection, even in non-diabetic CKD patients, as these have become a cornerstone of kidney protection 5. Newer mineralocorticoid receptor antagonists (like finerenone) may provide additional cardiovascular and renal benefits 4, 5.
Important Caveats for This Patient
While the <120 mmHg target is appropriate for most 67-year-olds with CKD, monitor closely and individualize if the patient has:
- Advanced CKD (stage G4-G5): Evidence is weaker; increased risk of acute kidney injury with intensive control 1, 4
- Diabetes: Less robust evidence in this subgroup 1, 2
- Significant proteinuria (>1 g/day): Risk-benefit less certain 2
- Very low diastolic BP: Increased perfusion concerns 1
- Frailty or orthostatic symptoms: Higher fall risk 4, 6
Monitoring Strategy
Track these parameters at each visit:
- Home BP readings (consider home BP monitoring for better control) 7, 3
- Body weight at every visit and trajectory over time 6
- Orthostatic BP changes if symptomatic 6
- Serum creatinine and eGFR serially to detect hypoperfusion-related AKI 6
- Electrolytes regularly, as intensive BP control increases risk of abnormalities 8
Seasonal Considerations
Reassess antihypertensive dosing during warm weather in this older adult. Seasonal BP declines combined with fixed-dose prescribing can lead to symptomatic hypotension, falls, volume depletion, and AKI 6. Monitor home BP trends and body weight more frequently during temperature transitions 6.
Lifestyle Modifications
Implement these non-pharmacologic measures:
- Sodium restriction to <5 g/day (approximately 2 g sodium) 1, 5
- Regular physical activity: 150 minutes per week 5
- Mediterranean or vegetarian diet pattern 5
- Protein intake of 0.8 g/kg/day 5
The evidence supporting the <120 mmHg target is strongest for cardiovascular protection and mortality reduction, not kidney protection 1, 2. Long-term data suggest some renoprotective benefit in patients with proteinuria, but overall kidney-specific evidence at this BP level is limited 1, 8.